Interesting that IDT's market cap is still less than $40m considering the potential sales of Temozolomide alone ...
The original (Temodar) had sales, before the parent exipired in 2013, of over $800M !
http://www.fiercepharma.com/special-report/temodar
The initial stock quantities manufactured for Mayne had been expected to satisfy demand until mid-2017 but uptake has been better than anticipated, demanding earlier than expected replenishment - for the higher dose strengths of 180mg and 250mg.
So that's only Temozolomide.
There is also a minimum of 6 further products "that should attain marketable status this calendar year".
Kinda surprising that the s/p is less than 20c
- Forums
- ASX - By Stock
- IDT
- Ann: Generics Sales Update
Ann: Generics Sales Update, page-7
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IDT (ASX) to my watchlist
|
|||||
Last
12.5¢ |
Change
0.010(8.70%) |
Mkt cap ! $53.69M |
Open | High | Low | Value | Volume |
12.0¢ | 13.0¢ | 12.0¢ | $99.94K | 818.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 320 | 12.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.0¢ | 53148 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 320 | 0.125 |
2 | 174048 | 0.120 |
5 | 204826 | 0.115 |
5 | 297166 | 0.110 |
5 | 535238 | 0.105 |
Price($) | Vol. | No. |
---|---|---|
0.130 | 53148 | 2 |
0.135 | 148000 | 2 |
0.140 | 361632 | 8 |
0.145 | 158627 | 3 |
0.150 | 265870 | 4 |
Last trade - 15.48pm 09/08/2024 (20 minute delay) ? |
Featured News
IDT (ASX) Chart |